Skip to content

Randomized controlled Trial for a New Nasopharyngeal Airway Versus Nasal cannula during Intravenous Anesthesia for Gastrointestinal Endoscopic Mini-Invasive Surgery

Randomized controlled Trial for a New Nasopharyngeal Airway Versus Nasal cannula during Intravenous Anesthesia for Gastrointestinal Endoscopic Mini-Invasive Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000030462
Enrollment
Unknown
Registered
2020-03-02
Start date
2019-05-31
Completion date
Unknown
Last updated
2020-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Minimally invasive treatment of digestive endoscopy under intravenous general anesthesia

Interventions

1:The new nasopharyngeal airway provides oxygen
2:The nasal cannula provides oxygen

Sponsors

Department of anesthesiology, Shengjing Hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. the patient required or agreed to perform gastrointestinal endoscopic mini-invasive surgery under general anesthesia; 2. there is no taboo on the selection of anesthetic drugs for this experiment; 3. received preoperative electrocardiogram, and other examinations, no obvious abnormalities; 4. sign preoperative anesthesia informed consent; 5. anesthesia class ASA I or II; 6. Aged 18-80 years old, BMI<28kg /m3 male or non-pregnant female patients.

Exclusion criteria

Exclusion criteria: 1. nasal polyps, nasal bleeding or bleeding tendency, nasal trauma, nasal malformation, nasal inflammation and other nasopharyngeal airway taboo; 2. gastrointestinal endoscopic contraindications such as coagulation mechanism disorders, gastrointestinal tract infection, and continued use of anticoagulants; 3. acute respiratory tract infection, asthma attack period and other respiratory system diseases; 4. not control of serious hypertension (higher than 180mmHg/80mmHg), serious arrhythmia, unstable angina and other circulatory system diseases.

Design outcomes

Primary

MeasureTime frame
Oxygen saturation;Percutaneous Pco2;

Countries

China

Contacts

Public ContactQi Wenyu

Shengjing Hospital of China Medical University

17702404643@163.com+86 17702404643

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026